发明授权
US5932227A Percutaneously administrable base composition and drug composition
prepared therefrom
失效
经皮给药的基础组合物和由其制备的药物组合物
- 专利标题: Percutaneously administrable base composition and drug composition prepared therefrom
- 专利标题(中): 经皮给药的基础组合物和由其制备的药物组合物
-
申请号: US374603申请日: 1995-03-29
-
公开(公告)号: US5932227A公开(公告)日: 1999-08-03
- 发明人: Naruhito Higo , Yukio Kojima , Ken-ichi Komori
- 申请人: Naruhito Higo , Yukio Kojima , Ken-ichi Komori
- 申请人地址: JPX Saga
- 专利权人: Hisamitsu Pharmaceutical Co., Inc.
- 当前专利权人: Hisamitsu Pharmaceutical Co., Inc.
- 当前专利权人地址: JPX Saga
- 优先权: JPX4-218369 19920723; JPX4-229226 19920804
- 主分类号: A61K9/00
- IPC分类号: A61K9/00 ; A61K47/00 ; A61K47/10 ; A61K47/14 ; A61K47/26 ; A61K47/38 ; A61K9/08
摘要:
A percutaneously administrable base composition which facilitates the percutaneous absorption of drugs and is remarkably reduced in the irritancy against the skin. The composition comprises 10-60 wt. % of lower alcohol, 10-50 wt. % of humectant, 10-70 wt. % of water, 0.1-15 wt. % of abirritant and 0.1-15 wt. % of absorption promoter. A drug composition is prepared by adding to the above composition various active ingredients such as antitussive, expectorant, skeletal muscle relaxant, antivertiginous drug, narcotic, drug for the circulatory system, and so forth.
公开/授权文献
- US4896835A Screening machine 公开/授权日:1990-01-30
信息查询